Skip to main content
SpringerLink
Log in

Clinical Trials (Clinical Perspective)

  • Chapter
Pediatric Inflammatory Bowel Disease

  • 799 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Griffiths AM. Specificities of inflammatory bowel disease. Best Pract & Res Clin Gastroenterol 2004;18:509–523.

    Article  Google Scholar 

  2. Carvalho RS, Abandom V, Dilworth HP, et al. Indeterminate colitis:a significant subgroup of pediatric IBD. Inflamm Bowel Dis 2006;12:258–262.

    Article  PubMed  Google Scholar 

  3. Griffiths AM, Otley AR, Hyams J. et al. A review of activity indices and end points for clinical trials in children with Crohn disease. Inflamm Bowel Dis 2005;11:185–196.

    Article  PubMed  Google Scholar 

  4. Sands BE, Abreu MT, Ferry G et al. Design issues and outcomes in IBD clinical trials. Inflamm Bowel Dis 2005;11:S22–S28.

    Article  PubMed  Google Scholar 

  5. Pappa HM, Semrin G, Walker TR, Grand RJ. Pediatric inflammatory bowel disease. Curr Opin Gastroenterol 2004;20:333–340.

    Article  PubMed  Google Scholar 

  6. Crofton PM, Kelnar CJH. Bone and collagen markers in pediatric practice. Int J Clin Pract 1998;52: 557–565.

    PubMed  CAS  Google Scholar 

  7. Kim SC, Ferry GD. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterology 2004;126:1550–1560.

    Article  PubMed  Google Scholar 

  8. Best W, Becktel J, Singleton J et al. Development of a Crohn disease activity index. Gastroenterology 1976;70:439–444.

    PubMed  CAS  Google Scholar 

  9. Hyams J, Ferry G, Mandel F, et al. Development and validation of a pediatric Crohn disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439–447.

    PubMed  CAS  Google Scholar 

  10. Kundhal PS, Critch JN, Zachos M, et al. Pediatric Crohn disease activity index:responsive to short-term change. J Pediatr Gastroenterol Nutr 2003;36:83–89.

    Article  PubMed  CAS  Google Scholar 

  11. Otley A, Loonen H, Parekh N, et al. Assessing activity of pediatric Crohn disease:which index to use? Gastroenterology 1999;116:527–531.

    Article  PubMed  CAS  Google Scholar 

  12. Hyams J, Markowitz J, Otley A, et al. Evaluation of the pediatric Crohn disease activity index: usefulness in the practice setting. J Pediatr Gastroenterol Nutr 2004;39 (Suppl):0712.

    Google Scholar 

  13. Hyams J, Markowitz J, Otley A, et al. Evaluation of the pediatric Crohn disease activity index:a prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005;41:416–421.

    Article  PubMed  Google Scholar 

  14. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. BMJ 1955;2:1041–8.

    Article  PubMed  CAS  Google Scholar 

  15. Powell-Tuck J, Bown RL, Lennard-Jones JE. A comparison of oral prednisone given as single or multiple daily doses for active ulcerative colitis. Scand J Gastroenterol 1978;13:833–7.

    Article  PubMed  CAS  Google Scholar 

  16. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in treatment of active ulcerative colitis: a randomised trial. BMJ 1989;298:82–6.

    PubMed  CAS  Google Scholar 

  17. Baron JH, Conell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearance in proctocolitis. BMJ 1964;1:89–92.

    PubMed  CAS  Google Scholar 

  18. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderate active ulcerative colitis. A randomised study. N Engl J Med 1987;317:1625–9.

    Article  PubMed  CAS  Google Scholar 

  19. D’Haens G, Hlavaty T. Advances in medical therapy for Crohn disease. Curr Gastroenterol Rep 2004;6:496–505.

    Article  PubMed  Google Scholar 

  20. Mamula P, Markowitz JE, Baldassano RN. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am 2003;32:867–995.

    Article  Google Scholar 

  21. Arnott ID, Watts D, Ghosh S. Review article:is clinical remission the optimum therapeutic goal in the treatment of Crohn disease? Aliment Pharmacol Ther 2002;16:857–67.

    Article  PubMed  CAS  Google Scholar 

  22. Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn disease. Gastrointest Endosc 2006;63:433–442.

    Article  PubMed  Google Scholar 

  23. Griffiths AM, Nicholas D, Smith C, et al. Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. J Pediatr Gastroenterol Nutr 1999;28:S46–S52.

    Article  PubMed  CAS  Google Scholar 

  24. Otley A, Smith C, Nicholas D, et al. The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002;35:557–563.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric and Liver Unit, Head, Pediatric Inflammatory Bowel Disease Center, Director, University Hospital Umberto I, University of Rome “La Sapienza”, Viale Regina Elena 324 – 00161 Rome, Italy

    Salvatore Cucchiara

Authors
  1. Salvatore Cucchiara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Osvaldo Borrelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Attending Physician, Division of GI Hepatology and Nutrition, Director Endoscopy Suite, The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Petar Mamula M.D. (Assistant Professor of Pediatrics) (Assistant Professor of Pediatrics)

  2. Attending Physician, Children’s Center for Digestive Health, Greenville Hospital System University Medical Center, University of South Carolina School of Medicine, Greenville, South Carolina, USA

    Jonathan E. Markowitz M.D., M.S.C.E. (Associate Professor of Clinical Pediatrics) (Associate Professor of Clinical Pediatrics)

  3. Attending Physician and Director, Inflammatory Bowel Disease Center Division of GI, Hepatology and Nutrition. The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Robert N. Baldassano M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Cucchiara, S., Borrelli, O. (2008). Clinical Trials (Clinical Perspective). In: Mamula, P., Markowitz, J.E., Baldassano, R.N. (eds) Pediatric Inflammatory Bowel Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-73481-1_40

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-73481-1_40

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-73480-4

  • Online ISBN: 978-0-387-73481-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation